Financing Through a Third-Party Allotment and Stock Acquisition Rights
First written in FY2017-Q1. 12 of 26 entries say "Restated". Latest entry: FY2026.
0 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「No. 11 Stock Acquisition Rights / Number of stock acquisition rights (units)* 1,400,000 / Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares, 140,000,000 shares」
The Company's No. 11 Stock Acquisition Rights covering 140,000,000 shares remained outstanding at the end of the fiscal year. The financing through convertible bonds with stock acquisition rights, which began in the previous fiscal year, had been fully converted, and this filing reconfirms that the No. 11 Stock Acquisition Rights remained in place. - FY2026-H1RestatedAnnual report
「② [Status of Other Stock Acquisition Rights, etc.] Not applicable.」
No issuance of new stock acquisition rights or other changes in status are reported in relation to the previous financing arrangements through the private placement capital increase and stock acquisition rights. - FY2025-H1AdvancedAnnual report
「During the interim consolidated accounting period, part of the First Series Unsecured Convertible Bonds with Stock Acquisition Rights was converted. ① Number of stock acquisition rights exercised: 6 units ② Class and number of shares issued: Common shares, 41,666,665 shares ③ Total exercise price: ¥300 million ④ Increase in share capital: ¥149.999 million ⑤ Increase in capital reserves: ¥149.999 million」
During the interim period, 6 units of the First Series Unsecured Convertible Bonds with Stock Acquisition Rights were converted, resulting in the issue of 41,666,665 common shares. A further 6 units were converted and 41,666,665 shares were issued by the filing date after the end of the interim period, indicating that execution of the financing arrangements had progressed from the previous filing. - FY2025-Q1AdvancedAnnual report
「The details of the First Series Unsecured Convertible Bonds with Stock Acquisition Rights converted after the day following the end of the first quarter consolidated accounting period through the filing date of this quarterly report are as follows: / (1) Number of stock acquisition rights exercised: 6 units / (2) Class and number of shares issued: Common shares, 41,666,665 shares / (3) Total exercise price: ¥300 million / (4) Increase in share capital: ¥149.999 million / (5) Increase in capital reserves: ¥149.999 million」
By the filing date, 6 units of the First Series Unsecured Convertible Bonds with Stock Acquisition Rights had been exercised, resulting in the issue of 41,666,665 common shares. Share capital and capital reserves each increased by ¥149.999 million, indicating that execution of the financing arrangements had progressed from the previous filing. - FY2024AdvancedAnnual report
「Increase in share capital from the conversion of convertible bonds with stock acquisition rights ¥74.999 million / Increase in capital reserves from the conversion of convertible bonds with stock acquisition rights ¥74.999 million」
The partial exercise of the First Series Unsecured Convertible Bonds with Stock Acquisition Rights resulted in the issue of 20,833,333 shares and an increase of ¥150 million in share capital and capital reserves. At the end of the period, ¥600 million of convertible bonds with stock acquisition rights and No. 11 Stock Acquisition Rights covering 140,000,000 shares remained outstanding, so the overall financing arrangements remained in place. As of the filing date, exercise of the No. 11 Stock Acquisition Rights had also been suspended in full through 2 November 2026. - FY2024-Q3AdvancedAnnual report
「The stock acquisition rights and bonds with stock acquisition rights issued under the Companies Act during the third quarter accounting period were as follows: / First Series Unsecured Convertible Bonds with Stock Acquisition Rights / Number of stock acquisition rights (units)* 15 / Balance of bonds with stock acquisition rights (yen)* ¥750,000,000 / No. 11 Stock Acquisition Rights / Number of stock acquisition rights (units)* 1,400,000 / Common shares 140,000,000 shares」
Following the completion of the previous financing arrangements through the No. 9 and No. 10 stock acquisition rights and other instruments, the Company issued ¥750 million of First Series Unsecured Convertible Bonds with Stock Acquisition Rights and No. 11 Stock Acquisition Rights, covering 140,000,000 underlying shares with an issue price of ¥1,120 million, on 2 November 2023. The exercise period for both instruments runs from 6 November 2023 to 2 November 2026. By the filing date, 3 units of the convertible bonds with stock acquisition rights had been exercised, resulting in the issue of 20,833,333 shares. - FY2024-Q1RestatedAnnual report
「② [Status of Other Stock Acquisition Rights, etc.] Not applicable.」
No issuance of new stock acquisition rights or other changes in status are reported, confirming again that the financing arrangements through the private placement capital increase and stock acquisition rights had ended. - FY2023-Q3RestatedAnnual report
「② [Status of Other Stock Acquisition Rights, etc.] Not applicable.」
No issuance of new stock acquisition rights or other changes in status are reported, confirming again that the financing arrangements through the private placement capital increase and stock acquisition rights had ended. - FY2022AchievedAnnual report
「The decrease in the Tenth Stock Acquisition Rights during the current consolidated fiscal year was due to the rights expiring.」
The balance of the Company's No. 10 stock acquisition rights, equivalent to 30,000,000 shares, decreased due to the expiration of the rights and stood at zero at the end of the fiscal year. The cancellation of the Class A shares and the exercise of the No. 9 stock acquisition rights had also been completed previously, and this filing shows that the Company's original financing arrangements through a private placement had ended. - FY2022-Q3RestatedAnnual report
「② [Status of Other Stock Acquisition Rights, etc.] Not applicable.」
No issuance of new stock acquisition rights or other changes in status at the end of the quarter were disclosed, and no new progress in the existing funding measures was indicated. - FY2022-Q2RestatedAnnual report
「1 June 2021–31 August 2021 － 1,440,974,000 － 50,000 － －」
There was no change during the quarter in the total number of issued shares, stated capital or capital reserves, and no progress in new share issuance through the existing stock acquisition rights as a funding measure was disclosed. - FY2022-Q1RestatedAnnual report
「1 March 2021–31 May 2021 － 1,440,974,000 － 50,000 － －」
There was no change during the quarter in the total number of issued shares, stated capital or capital reserves, and no progress in new share issuance through the exercise of the stock acquisition rights was disclosed. The status of the existing funding measures was reconfirmed. - FY2021-Q3RestatedAnnual report
「1 September 2020–30 November 2020 － 1,440,974,000 － 50,000 － －」
There was no change during the third quarter accounting period in the total number of issued shares, stated capital or capital reserves, and no progress in new share issuance through the stock acquisition rights was disclosed. Existing funding measures are continuing. - FY2021-Q2RestatedAnnual report
「1 June 2020–31 August 2020 － 1,440,974,000 － 50,000 － －」
There was no change during the second quarter accounting period in the total number of issued shares, stated capital or capital reserves, and no progress in new share issuance through the stock acquisition rights was disclosed. Existing funding measures are continuing. - FY2021-Q1RestatedAnnual report
「1 March 2020–31 May 2020 － 1,440,974,000 － 50,000 － －」
There was no change during the quarter in the total number of issued shares, stated capital or capital reserves, and no progress in new share issuance through the stock acquisition rights was disclosed. Existing funding measures remain outstanding. - FY2020RestatedAnnual report
「Number of shares underlying the stock acquisition rights: 30,000,000 (Note 1)」
Stock acquisition rights covering 30,000,000 shares under the Tenth Stock Acquisition Rights remained outstanding, and no new shares were issued during the fiscal year. Funding through the stock acquisition rights is continuing. - FY2019AdvancedAnnual report
「All Class A preferred shares were cancelled on 21 February 2019, pursuant to a resolution of the board of directors held on the same date.」
All 2,750,000 Class A preferred shares issued through a third-party allotment were cancelled. As 665,000,000 shares were issued through the stock acquisition rights during the fiscal year and 30,000,000 shares underlying the Tenth Stock Acquisition Rights remained outstanding at fiscal year-end, the overall funding process is not considered complete. - FY2019-Q3RestatedAnnual report
「During the nine-month period ended 31 December, the Ninth and Tenth Stock Acquisition Rights were partially exercised. As a result, stated capital and capital reserves each increased by ¥1,001,490 thousand from the end of the previous consolidated fiscal year, and at the end of the third quarter consolidated accounting period, stated capital amounted to ¥8,616,192 thousand and capital surplus to ¥8,380,912 thousand.」
The partial exercise of the Ninth and Tenth Stock Acquisition Rights and the resulting increases in stated capital and capital reserves are restated. No increase in the total number of issued shares or in stated capital and related items during the quarter is disclosed. - FY2019-Q2AdvancedAnnual report
「During the six-month period ended 30 September, the Ninth and Tenth Stock Acquisition Rights were partially exercised. As a result, stated capital and capital reserves each increased by ¥1,001,490 thousand from the end of the previous consolidated fiscal year, and at the end of the second quarter consolidated accounting period, stated capital amounted to ¥8,616,192 thousand and capital surplus to ¥8,380,912 thousand.」
The partial exercise of the Ninth and Tenth Stock Acquisition Rights progressed, increasing stated capital and capital reserves by ¥1,001,490 thousand each. The total number of issued shares also increased by 550,000,000 during the quarter. - FY2019-Q1AdvancedAnnual report
「During the three-month period ended 30 June, the Ninth Stock Acquisition Rights were partially exercised. As a result, stated capital and capital reserves each increased by ¥173,190 thousand from the end of the previous consolidated fiscal year, and at the end of the first quarter consolidated accounting period, stated capital amounted to ¥7,787,892 thousand and capital surplus to ¥7,552,612 thousand.」
The partial exercise of the Ninth Stock Acquisition Rights progressed during the quarter, increasing stated capital and capital reserves by ¥173,190 thousand each. The filing also states that a further 30,000,000 common shares were issued by the filing date and that stated capital and capital reserves each increased by ¥45,180 thousand. - FY2018AdvancedAnnual report
「Between 1 March and 24 May 2018, after the end of the consolidated fiscal year, the exercise of the Ninth Stock Acquisition Rights resulted in an increase of 90,000,000 in the total number of issued shares and increases of ¥135,540 thousand each in stated capital and capital surplus.」
During the fiscal year, the exercise of the Ninth Stock Acquisition Rights also increased stated capital and capital reserves by ¥120,480 thousand each. By the filing date, a further 90,000,000 shares had been issued and stated capital and capital surplus had each increased by ¥135,540 thousand. The funding process through the stock acquisition rights is progressing. - FY2018-Q3AdvancedAnnual report
「This resulted from the conversion of Class A preferred shares into common shares.」
On 28 September, 16 October and 22 November 2017, Class A preferred shares were converted into common shares, increasing common shares by 20,000 thousand, 25,000 thousand and 28,500 thousand shares, respectively. An increase in capital resulting from the partial exercise of the Ninth Stock Acquisition Rights was also disclosed. - FY2018-Q2AdvancedAnnual report
「During the six-month period ended 30 September, EVO FUND partially exercised the Ninth Stock Acquisition Rights. As a result, stated capital and capital reserves each increased by ¥120,480 thousand from the end of the previous consolidated fiscal year, and at the end of the second quarter consolidated accounting period, stated capital amounted to ¥7,614,702 thousand and capital surplus to ¥7,379,422 thousand.」
EVO FUND's partial exercise of the Ninth Stock Acquisition Rights progressed, increasing stated capital and capital reserves by ¥120,480 thousand each. The execution of the funding measure progressed further than in the previous quarter. - FY2017AdvancedAnnual report
「Increase resulting from the exercise of stock acquisition rights」
The exercise of the Ninth Stock Acquisition Rights resulted in the issuance of 50,000 thousand shares, increasing stated capital and capital reserves by ¥75,300 thousand each. At the end of the fiscal year, 225,000 thousand Ninth Stock Acquisition Rights and 550,000 thousand Tenth Stock Acquisition Rights remained outstanding. - FY2017-Q2AchievedAnnual report
「To address these issues, on 1 June 2016, the group issued Class A preferred shares through a third-party allotment to EVO FUND, as well as the Ninth and Tenth Stock Acquisition Rights.」
The issuance of Class A preferred shares, the Ninth and Tenth Stock Acquisition Rights, and the payment for the third-party allotment capital increase were completed, concluding the issuance procedures as a funding measure. The exercise period for the stock acquisition rights remains open until 1 June 2021. - FY2017-Q1First statedAnnual report
「The company resolved to issue class shares through a private placement to EVO FUND, as well as the Ninth and Tenth Series of Stock Acquisition Rights.」
On 1 June 2016, the company received payment for 2,750,000 Class A shares with an aggregate issue price of ¥825 million. The potential number of shares under the Ninth and Tenth Series of Stock Acquisition Rights was 275,000,000 and 550,000,000, respectively, and both exercise periods ran from 1 June 2016 to 1 June 2021. The proceeds were intended for settlement funds and other costs associated with acquiring real estate projects.